Clinical trials
Acute Coronary Syndrome trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
176 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 4 |
| 2008 | 5 |
| 2009 | 5 |
| 2010 | 9 |
| 2011 | 3 |
| 2012 | 5 |
| 2013 | 6 |
| 2014 | 10 |
| 2015 | 5 |
| 2016 | 8 |
| 2017 | 9 |
| 2018 | 12 |
| 2019 | 15 |
| 2020 | 7 |
| 2021 | 11 |
| 2022 | 8 |
| 2023 | 12 |
| 2024 | 17 |
| 2025 | 15 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 63 |
| Unknown status | 62 |
| Recruiting | 32 |
| Not yet recruiting | 12 |
| Active, not recruiting | 5 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shenyang Northern Hospital | 9 |
| Beijing Anzhen Hospital | 8 |
| Qilu Hospital of Shandong University | 7 |
| AstraZeneca | 6 |
| Harbin Medical University | 6 |
| The First Affiliated Hospital of Dalian Medical University | 5 |
| China National Center for Cardiovascular Diseases | 4 |
| Chinese PLA General Hospital | 4 |
| Jiangsu vcare pharmaceutical technology co., LTD | 4 |
| RenJi Hospital | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acute Coronary Syndrome | 176 |
| Coronary Artery Disease | 16 |
| Myocardial Ischemia | 11 |
| Coronary Disease | 10 |
| Myocardial Infarction | 9 |
| Cardiovascular Diseases | 7 |
| ST Elevation Myocardial Infarction | 7 |
| Angina, Unstable | 6 |
| Chest Pain | 5 |
| Arterial Occlusive Diseases | 4 |
Trials
Showing 76 to 100 of 176. Each trial links to its page on Pharma Observatory.
76 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.